Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)

ClinicalTrials.gov ID: NCT03657342

Public ClinicalTrials.gov record NCT03657342. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Single Lung Transplant

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this trial is to assess the efficacy and safety of aerosolized liposomal cyclosporine A (L-CsA) as add-on therapy to standard of care (SoC) as compared to SoC alone in single lung transplant recipients with chronic lung allograft dysfunction (CLAD)-bronchiolitis obliterans syndrome (BOS).

Study identification

NCT ID
NCT03657342
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Zambon SpA
Industry
Enrollment
62 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 26, 2019 (Actual)
Primary completion
Apr 16, 2024 (Actual)
Completion
Apr 16, 2024 (Actual)
Last update posted
Oct 27, 2025

2019 – 2024

United States locations

U.S. sites
25
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Banner Health Phoenix Arizona 85013 —
Norton Thoracic Institute at St. Joseph's Hospital Phoenix Arizona 85013 —
UCLA Medical Center Los Angeles California 90095 —
Stanford University Hospital Palo Alto California 94305 —
UC San Francisco San Francisco California 94143 —
University of Florida Medical Center Gainesville Florida 32608 —
Mayo Clinic Jacksonville Jacksonville Florida 32224 —
University of South Florida Tampa Florida 33606 —
Indiana University Health Methodist Hospital Indianapolis Indiana 46202 —
University of Kentucky Albert B. Chandler Hospital Lexington Kentucky 40508 —
University of Maryland Baltimore Maryland 21201 —
Johns Hopkins University Hospital Baltimore Maryland 21287 —
110 St Louis Missouri 63110 —
Columbia University Medical Center New York New York 10032 —
113 New York New York 22042 —
Duke University Medical Center Durham North Carolina 27710 —
Cleveland Clinic Cleveland Ohio 44195 —
119 Columbus Ohio 43210 —
108 Philadelphia Pennsylvania 19104 —
Temple University Hospital Philadelphia Pennsylvania 19140 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 —
Baylor University Medical Center Dallas Texas 75246 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
Baylor St. Luke's Medical Center Houston Texas 77030 —
Houston Methodist Hospital Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03657342, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 27, 2025 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03657342 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →